Articles

Diminished Big Mac appetite is a sign of deflationary trend, says Yardeni

Retailers are cutting prices to attract consumers, as deflationary trends show up at McDonald’s Corp. as well as in commodity markets and durables goods, according to Yardeni Research.

Job openings fall slightly, with labor market still strong but cooling

Job openings in the U.S. fell slightly in June to just above 8 million as the labor market continued to cool, but there are still more jobs available than there were before the pandemic.

Consumer confidence picks up a bit in July

Consumer confidence has been relatively soft all year and very choppy for the last four months.

13 value stocks for patient investors looking for long-term growth

A value manager with an excellent decades-long performance record supplies “a baker’s dozen of big bargains.”

Treasury yields hold steady amid receding angst over supply

Treasury yields turned little changed Tuesday morning amid fading concerns about the supply of U.S. government debt after the Treasury Department downwardly revised its third-quarter borrowing estimate.

Home prices hit a new high in May, Case-Shiller says, but are losing steam

Buyers waiting for U.S. mortgage rates to drop before buying might find it “costly.”

‘For the record, I trust him 100%’: Should my husband and I add our son to our bank accounts in case something happens to us?

‘I am not worried that if we make him a joint owner on our bank accounts that something nefarious would happen’

P&G’s stock pulls back from a record as profit beats but sales surprisingly fall

Shares of Procter & Gamble Co. were knocked lower in early Tuesday trading, after the consumer packaged-goods company reported fiscal fourth-quarter profit that beat expectations but also a surprise dip in sales.

Tesla recalling over 1.8 million cars in the U.S. over hood issue, says NHTSA

Software may fail to detect an unlatched hood on some Tesla vehicles, according to the National Highway Traffic Safety Administration.

Merck’s stock drops as mixed outlook offsets earnings beat on Keytruda strength

Merck’s stock was headed lower in early trading Tuesday, after the drugmaker reported second-quarter profit and sales that beat expectations, amid strength in sales of cancer treatment Keytruda, but provided a mixed full-year outlook.

Archer Daniels Midland’s stock drops as earnings and revenue fall short of estimates

ADM said it faced “challenging market conditions” and that large South American crops and shifts in farmer selling behaviors impacted its second-quarter results, but it expects margin opportunities to improve.

Pfizer’s stock pops after earnings beat as company raises guidance and unveils cost cuts

Pfizer offered an update on a cost-cutting program and raised full-year guidance on Tuesday.
1 908 909 910 911 912 2,300